Cell-Cell Sensing of Viral Infection by Plasmacytoid Dendritic Cells
Overview
Authors
Affiliations
All cells possess signaling pathways designed to trigger antiviral responses, notably characterized by type I interferon (IFN) production, upon recognition of invading viruses. Especially, host sensors recognize viral nucleic acids. Nonetheless, virtually all viruses have evolved potent strategies that preclude host responses within the infected cells. The plasmacytoid dendritic cell (pDC) is an immune cell type known as a robust type I IFN producer in response to viral infection. Evidence suggests that such functionality of the pDCs participates in viral clearance. Nonetheless, their contribution, which is likely complex and varies depending on the pathogen, is still enigmatic for many viruses. pDCs are not permissive to most viral infections, and consistently, recent examples suggest that pDCs respond to immunostimulatory viral RNA transferred via noninfectious and/or noncanonical viral/cellular carriers. Therefore, the pDC response likely bypasses innate signaling blockages induced by virus within infected cells. Importantly, the requirement for cell-cell contact is increasingly recognized as a hallmark of the pDC-mediated antiviral state, triggered by evolutionarily divergent RNA viruses.
Suvieri C, Mondanelli G, Orabona C, Pallotta M, Panfili E, Rossini S Cells. 2024; 13(13.
PMID: 38994942 PMC: 11240372. DOI: 10.3390/cells13131088.
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma.
Gardam B, Gargett T, Brown M, Ebert L Front Immunol. 2023; 14:1261257.
PMID: 37928547 PMC: 10623138. DOI: 10.3389/fimmu.2023.1261257.
Tracking Plasmacytoid Dendritic Cell Response to Physical Contact with Infected Cells.
Ribeiro M, Joshi G, Decembre E, Nuovo C, Bosseboeuf A, Bellomo A Methods Mol Biol. 2023; 2618:289-315.
PMID: 36905525 DOI: 10.1007/978-1-0716-2938-3_21.
Moore-Fried J, Paul M, Jing Z, Fooksman D, Lauvau G Elife. 2022; 11.
PMID: 36278864 PMC: 9648966. DOI: 10.7554/eLife.78873.
Gene Therapy as a Potential Treatment for Patients with COVID-19.
Harford J, Kim S, Pirollo K, Chang E Viruses. 2022; 14(4).
PMID: 35458469 PMC: 9027273. DOI: 10.3390/v14040739.